FITC anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_FITC_082808.jpg
BALB/cmouse bone marrow cells stained with 1A8 FITC (gated on myeloid cells)
  • 1A8_FITC_082808.jpg
    BALB/cmouse bone marrow cells stained with 1A8 FITC (gated on myeloid cells)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
127605 50 µg 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127606 500 µg 210€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Valladao A, et al. 2016. J Immunol. 197(12):4541-4551. PubMed
  2. Campbell IK, Leong D 2016. J Immunol. 197(11):4392-4402. PubMed
  3. Sun L, et al. 2021. Cancer Cell. :. PubMed
  4. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  5. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  6. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  7. Gordan S, et al. 2020. Cell Reports. 29(10):3033-3046.e4.. PubMed
  8. Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed
  9. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  10. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  11. Long M, et al. 2017. J Immunol. 198(2):862-872. PubMed
  12. Oliveira-Lima OC, et al. 2015. Immunobiology. . PubMed
  13. Mandraju R, et al. 2014. J Immunol. 192:4303. PubMed
  14. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  15. He R, et al. 2021. J Immunol. 206:2353. PubMed
  16. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  17. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  18. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  19. Tripathi H, et al. 2020. J Mol Cell Cardiol. 149:95. PubMed
  20. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  21. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  22. Patsalos A, et al. 2019. J Immunol. 203:1532. PubMed
  23. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  24. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  25. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  26. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  27. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  28. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  29. Torre S, et al. 2016. Nat Immunol. 10.1038/ni.3581. PubMed
  30. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  31. Wang C, et al. 2015. Sci Rep. 5: 14124. PubMed
  32. Huai W, et al. 2019. J Exp Med. 216:772. PubMed
  33. Han J, et al. 2022. FEBS J. 289:417. PubMed
  34. Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
  35. Castiglioni A, et al. 2015. PLoS One. 10:128094. PubMed
  36. Guesdon W, et al. 2015. J Infect Dis. 212: 1332 - 1340. PubMed
  37. Strother R, et al. 2016. J Immunol. 197(11):4301-4311. PubMed
  38. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  39. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  40. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  41. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  42. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  43. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  44. Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
  45. Diao N, et al. 2016. Sci Rep. 6:34672. PubMed
  46. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  47. Fujikura D, et al. 2013. PLoS One. 8:e55321. PubMed
  48. Ueki H, et al. 2020. Nat Protoc. 15:1041. PubMed
  49. Saika A, et al. 2020. FASEB Bioadv. 2:59. PubMed
  50. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  51. Wang H et al. 2017. Developmental cell. 40(6):566-582 . PubMed
  52. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
  53. Billi AC, et al. 2019. JCI Insight. 4:8. PubMed
  54. Han YH, et al. 2021. Science. 373:. PubMed
  55. Abad C, et al. 2014. J Leukoc Biol. 95:357. PubMed
  56. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  57. Liu Z, et al. 2016. J Biol Chem. 291: 1441 - 1447. PubMed
  58. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  59. Na YR, et al. 2020. Cell Rep. 107643:31. PubMed
  60. Wang L, et al. 2017. Front Immunol.. 10.3389/fimmu.2017.01754. PubMed
  61. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
  62. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  63. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  64. Wu X, et al. 2021. Elife. 10:. PubMed
  65. Opzoomer JW, et al. 2021. Sci Adv. 7:eabg9518. PubMed
  66. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  67. Jacome-Galarza C, et al. 2011. J Bone Miner Res. 26:1207. PubMed
  68. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  69. Jin RM, et al. 2017. J Immunol. 198:352. PubMed
  70. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  71. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  72. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  73. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  74. Korangath P, et al. 2020. Bio Protoc. 10:e3822. PubMed
  75. Minogue A, et al. 2014. Neurobiol Aging. 35:1442. PubMed
  76. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  77. Zheng J, et al. 2020. bioRxiv. . PubMed
  78. Huixin Xu et al. 2018. EMBO molecular medicine. 10(9) pii: e8931. PubMed
  79. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  80. Geng S, et al. 2021. JCI Insight. 6:. PubMed
  81. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  82. Morales-Mantilla DE, et al. 2022. Elife. 11:. PubMed
  83. Chen M, et al. 2021. Oncol Lett. 21:435. PubMed
  84. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  85. Gousopoulos E, et al. 2016. Am J Pathol. 186:2193-2203. PubMed
  86. Radjabova V, et al. 2015. J Immunol. 195: 3149 - 3159. PubMed
  87. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  88. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  89. Mishra BB, et al. 2017. Nat Microbiol. 2:17072. PubMed
  90. Roy K, et al. 2019. Immunity. 50:616. PubMed
  91. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  92. Christ A, et al. 2018. Cell. 172:162. PubMed
  93. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  94. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  95. Wu M, et al. 2013. Proc Natl Acad Sci U S A. 110:9439. PubMed
  96. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  97. Ericson J, et al. 2014. PLoS One. 9:108553. PubMed
  98. Shih Y, et al. 2015. JPEN J Parenter Enteral Nutr. . PubMed
  99. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  100. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  101. He J, et al. 2019. J Clin Invest. 130. PubMed
  102. Yu L, et al. 2019. Elife. 8:e46677. PubMed
  103. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  104. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  105. Flögel U, et al. 2021. Nat Commun. 12:5847. PubMed
  106. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  107. Zheng J, et al. 2020. Nature. . PubMed
  108. Kim P, et al. 2015. Infect Immun . 83: 2992 - 3002. PubMed
  109. Fischer KJ, et al. 2019. J Immunol. 202:2027. PubMed
  110. Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
  111. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  112. Uderhardt S, et al. 2019. Cell. 177:541. PubMed
  113. Hermetet F, et al. 2019. Nat Commun. 10:523. PubMed
  114. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  115. Shevchenko MA, et al. 2018. J Immunol Res. 8:53. PubMed
  116. Simpson K, et al. 2012. J Immunol. 189:5533. PubMed
  117. Giampazolias E, et al. 2021. Cell. . PubMed
  118. Prizant H, et al. 2021. Cell Reports. 36(6):109523. PubMed
  119. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  120. Rebecca S Dickinson et al. 2017. Wellcome open research. 0.155555556 . PubMed
  121. Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed
  122. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  123. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  124. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  125. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  126. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  127. Winchell CG, et al. 2020. Front Immunol. 1.077083333. PubMed
  128. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  129. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  130. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  131. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  132. Qin W, et al. 2022. Bio Protoc. 12:e4287. PubMed
  133. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  134. Shibuya M, et al. 2021. iScience. 24:103131. PubMed
  135. Gorina R, et al. 2014. J Immunol. 192:324. PubMed
  136. Nacer A, et al. 2014. PLoS Pathog. 10:1004528. PubMed
  137. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  138. Varikuti S, et al. 2020. Br J Cancer. 122:1005. PubMed
  139. Thomas DG et al. 2018. Cell reports. 25(13):3774-3785 . PubMed
  140. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  141. Chen ST et al. 2019. Cell host & microbe. 25(4):602-616 . PubMed
  142. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  143. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  144. LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed
  145. Makino A, et al. 2021. iScience. 24:103201. PubMed
  146. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  147. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  148. Wei Y, et al. 2021. Endocrinology. 162(8):. PubMed
  149. Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
  150. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  151. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  152. van Geffen C, et al. 2021. Front Immunol. 12:695933. PubMed
  153. Gu H, et al. 2021. Elife. 10:. PubMed
  154. Issah Y, et al. 2021. Elife. 10:. PubMed
  155. Danzer H, et al. 2020. Elife. 9:00. PubMed
  156. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  157. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  158. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  159. Chen J, et al. 2014. Cell Res. 24:1050. PubMed
  160. Xu Y, et al. 2014. Proc Natl Acad Sci U S A. 111:6371. PubMed
  161. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  162. Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed
  163. Nakamura K, et al. 2018. Cancer Cell. 33:634. PubMed
  164. Smith LK, et al. 2021. Elife. 10:. PubMed
  165. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  166. Stadtmann A, et al. 2015. J Immunol. 195: 1152-1161. PubMed
  167. Jia H, et al. 2016. J Immunol. 197: 859 - 871. PubMed
  168. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  169. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  170. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  171. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  172. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  173. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  174. Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
  175. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  176. Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
  177. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  178. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  179. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  180. Zhang H, et al. 2022. Commun Biol. 5:916. PubMed
  181. Singh N, et al. 2016. Dis Model Mech. 9: 885 - 897. PubMed
  182. Cojohari O, Peppenelli M, Chan G 2016. Blood. 128: 529 - 541. PubMed
  183. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
  184. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  185. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  186. Chuang LT, et al. 2021. Molecules. 26:. PubMed
RRID
AB_1236488 (BioLegend Cat. No. 127605)
AB_1236494 (BioLegend Cat. No. 127606)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F
Purified anti-mouse Ly-6G 1A8 FC, IHC-F, IHC
Biotin anti-mouse Ly-6G 1A8 FC, IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC, IHC-F
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC, IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC, IHC-F, SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC, IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC, Depletion, IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC, CyTOF®, WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Go To Top Version: 3    Revision Date: 01.06.2017

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Alexa Fluor® 594 anti-mouse Ly-6G

  • Purified anti-mouse Ly-6G

  • Biotin anti-mouse Ly-6G

  • FITC anti-mouse Ly-6G

  • PE anti-mouse Ly-6G

  • Alexa Fluor® 647 anti-mouse Ly-6G

  • Pacific Blue™ anti-mouse Ly-6G

  • APC anti-mouse Ly-6G

  • PerCP/Cyanine5.5 anti-mouse Ly-6G

  • PE/Cyanine7 anti-mouse Ly-6G

  • Alexa Fluor® 700 anti-mouse Ly-6G

  • APC/Cyanine7 anti-mouse Ly-6G

  • Alexa Fluor® 488 anti-mouse Ly-6G

  • Brilliant Violet 421™ anti-mouse Ly-6G

  • Brilliant Violet 570™ anti-mouse Ly-6G

  • Ultra-LEAF™ Purified anti-mouse Ly-6G

  • Brilliant Violet 510™ anti-mouse Ly-6G

  • Purified anti-mouse Ly-6G (Maxpar® Ready)

  • Brilliant Violet 650™ anti-mouse Ly-6G

  • Brilliant Violet 711™ anti-mouse Ly-6G

  • Brilliant Violet 605™ anti-mouse Ly-6G

  • Brilliant Violet 785™ anti-mouse Ly-6G

  • PE/Dazzle™ 594 anti-mouse Ly-6G

  • APC/Fire™ 750 anti-mouse Ly-6G

  • PerCP anti-mouse Ly-6G

  • TotalSeq™-A0015 anti-mouse Ly-6G

  • TotalSeq™-C0015 anti-mouse Ly-6G

  • TotalSeq™-B0015 anti-mouse Ly-6G

  • Spark Blue™ 550 anti-mouse Ly-6G

  • Spark NIR™ 685 anti-mouse Ly-6G

  • Spark YG™ 593 anti-mouse Ly-6G

  • APC/Fire™ 810 anti-mouse Ly-6G Antibody

  • PE/Cyanine5 anti-mouse Ly-6G

  • PE/Fire™ 810 anti-mouse Ly-6G Antibody

  • Spark UV™ 387 anti-mouse Ly-6G

  • PE/Fire™ 640 anti-mouse Ly-6G

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account